ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
548 hedge funds and large institutions have $26.9B invested in Alexion Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 191 increasing their positions, 193 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1% less repeat investments, than reductions
Existing positions increased: 191 | Existing positions reduced: 193
4% less call options, than puts
Call options by funds: $394M | Put options by funds: $412M
Holders
548
Holding in Top 10
24
Calls
$394M
Puts
$412M
Top Buyers
| 1 | +$408M | |
| 2 | +$261M | |
| 3 | +$211M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$166M |
| 5 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$149M |
Top Sellers
| 1 | -$981M | |
| 2 | -$480M | |
| 3 | -$189M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$125M |
| 5 |
Goldman Sachs
New York
|
-$115M |